IMMUNITYBIO, INC. |
Market Closed -
Other stock markets
|
After market 05:22:20 am | |||
| 8.99 USD | +22.31% |
|
8.975 | -0.17% |
Chart calendar ImmunityBio, Inc.
52.Af0k6SupR2ARXQgK3R1Fjz-e8-tT7dBhCL1szerypxw.aJNBh3nRBiZXC2palE0mymjvxqwYnpMEYMsPhomV0ldEn0OuSJhxE3MOQQ~0bcaabe6860080a4c1398ff9750934e3
Upcoming events on ImmunityBio, Inc.
Past events on ImmunityBio, Inc.
| 26/04/2024 08:30 pm | ANKTIVA® FDA Approval Call |
| 30/11/2023 09:00 pm | Piper Sandler Healthcare Conference |
| 04/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number :358 |
| 02/11/2023 | LUGPA Meeting |
| 01/11/2023 | Society for Immunotherapy of Cancer Meeting |
| 07/07/2023 | AACR - AHNS Joint Conference |
| 13/06/2023 10:00 pm | Annual General Meeting |
| 13/06/2023 10:00 pm | Annual General Meeting |
| 07/06/2023 07:30 pm | Jefferies Global Healthcare Conference |
| 02/06/2023 | ASCO Meeting |
| 28/04/2023 | American Urological Association Meeting - Booth no. 3807 |
| 28/03/2023 | Hanson Wade Innate Killer Summit |
| 17/02/2023 01:00 am | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No: 495 |
| 19/01/2023 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
| 30/11/2022 01:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 15/11/2022 09:55 pm | Jefferies London Healthcare Conference |
| 08/08/2022 | Interim 2022 Earnings Release |
| 14/06/2022 10:00 pm | Annual General Meeting |
| 03/06/2022 | American Society of Clinical Oncology Meeting - QUILT 88 Poster Session |
| 03/06/2022 | American Society of Clinical Oncology Meeting - QUILT 3.032 Oral Presentation |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,93 0,57 64.15% | 0,24 0,30 -18.92% | 0,62 0,51 22.44% | 9,68 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -330 -331 0.21% | -351 -335 -4.74% | -362 -357 -1.52% | -332 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -350 -341 -2.51% | -417 -398 -4.82% | -584 -474 -23.26% | -439 |
|
Net income Million USD | Released Forecast Spread | -347 -341 -1.62% | -417 -398 -4.64% | -583 -474 -23.11% | -437 |
|
EPS USD | Released Forecast Spread | -0,89 -1,35 34.07% | -1,04 -0,94 -10.64% | -1,15 -0,93 -23.66% | -0,75 |
| Announcement Date | 01/03/22 | 01/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,39 0,03 1460% | 0,01 0,03 -44% | 0,04 | 0,12 0,06 88.8% | 0,07 0,03 192% | 0,36 0,03 1340% | 0,04 0,03 64% | 0,08 0,40 -79.5% | 0,14 0,03 456% | 0,03 | 2,53 | 10,0 | 22,7 | 35,0 |
|
EBIT Million USD | Released Forecast Spread | -79,3 -80,0 0.88% | -96,0 -80,0 -20% | -90,8 -75,0 -21.11% | -84,9 -75,0 -13.24% | -112 -95,0 -17.48% | -85,1 -100,0 14.83% | -80,1 -73,0 -9.78% | -85,4 -80,0 -6.77% | -87,5 | -90,9 | -85,7 | -78,7 | -68,6 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -91,6 -83,0 -10.33% | -103 -85,7 -20.25% | -111 -86,3 -28.79% | -108 -89,1 -21.55% | -117 -109 -6.5% | -138 -116 -19.62% | -95,6 -80,5 -18.81% | -233 -123 -89.39% | -111 | -115 | -109 | -103 | -93,0 | |
|
Net income Million USD | Released Forecast Spread | -91,3 -83,0 -9.97% | -103 -85,7 -20.05% | -111 -86,3 -28.53% | -108 -89,1 -21.46% | -116 -109 -6.28% | -138 -116 -19.33% | -95,6 -79,7 -20% | -233 -123 -89.34% | -111 | -115 | -109 | -103 | -93,0 | |
|
EPS USD | Released Forecast Spread | -0,23 -0,21 -9.52% | -0,26 -0,22 -18.18% | -0,24 -0,24 0% | -0,28 -0,22 -30.23% | -0,27 -0,17 -63.64% | -0,27 -0,27 0% | -0,32 -0,24 -36.17% | -0,19 -0,18 -5.56% | -0,38 -0,18 -111.11% | -0,16 | -0,17 | -0,16 | -0,15 | -0,14 |
| Announcement Date | 01/03/22 | 10/05/22 | 08/08/22 | 09/11/22 | 01/03/23 | 11/05/23 | 08/08/23 | 09/11/23 | 19/03/24 | - | - | - | - | - |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for ImmunityBio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IBRX Stock
- Calendar ImmunityBio, Inc.
